Weight-Loss Medications in New Zealand: Insights from Experts

With the availability of weight loss medications like Wegovy and Saxenda in New Zealand, interest in GLP-1s has surged, but experts caution that without personalized support, users, particularly women, may face nutrient deficiencies. Research indicates that around 10% of individuals on GLP-1s experience nutritional deficiencies within six months, increasing to 20% after a year, along with potential muscle loss and reduced bone density.

Want More Context? 🔎